Table 5.
Variable | Lowest-cost regimen | Highest-cost regimen | ||
---|---|---|---|---|
|
|
|||
Drug | 90-d cost, $ | Drug | 90-d cost, $ | |
Drug class | ||||
| ||||
Angiotensin-converting-enzyme inhibitors | 90-d ramipril (generic) | 11.83 | 30-d lisinopril (generic) | 76.01 |
| ||||
Antiplatelet agents | 90-d ASA (generic) | 10.35 | 30-d ASA (generic) | 21.90 |
| ||||
Direct factor Xa inhibitors | 90-d rivaroxaban (brand-name) | 129.15 | 30-d rivaroxaban (brand-name) | 129.15 |
| ||||
Statins | 90-d rosuvastatin (generic) | 19.71 | 30-day rosuvastatin (generic) | 50.16 |
| ||||
Potential cost savings, $ | ||||
| ||||
Total quarterly cost | 171.04 | 277.22 | ||
| ||||
Potential quarterly savings | 106.18 | — | ||
| ||||
Total monthly cost | 57.01 | 92.41 | ||
| ||||
Potential monthly savings | 35.40 | — |
ASA = acetylsalicylic acid.